Get the latest market trends in your inbox

Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sen. Jeff Merkley. Photo: J. Scott Applewhite / AP

Sen. Jeff Merkley says domestic solar manufacturers should be helped by incentives instead of tariffs to compete with cheap imports, putting the Oregon Democrat on the side of most of the solar industry and against an Oregon-based manufacturer seeking tariffs from President Trump.

Why it matters: Merkley personifies the challenge facing clean-energy advocates in the pending solar trade battle: He wants to support renewable energy whenever possible, but one of his constituents is telling him cheap imports is hurting his home-state solar manufacturer. Merkley's comments to Axios, made earlier this month on the sidelines of a climate conference in Bonn, Germany, are the first the senator has made on the trade case.

"I would like to see us to take an approach that would assist the American companies so they could lower their prices and compete with industry at lower prices," Merkley said in the interview. He said subsidies to U.S. companies would be a "real win-win."

Two foreign-owned but U.S.-based solar manufacturers — Georgia-based Suniva and Oregon-based SolarWorld — are asking the Trump administration to impose tariffs on cheap solar imports. Most experts say tariffs would hurt deployment of American solar energy because the U.S. industry depends heavily on cheap panels from China and other Asian countries, but there's less consensus about how big the impact could be, while other experts say a remedy could at least temporarily help domestic panel makers.

For the record: A SolarWorld representative said the company appreciated Merkley's advocacy but added: "We believe that an appropriate remedy by the President to save and rebuild U.S. solar manufacturing must include tariffs and quotas as well as funding or incentives."

What's next: The United States Trade Representative holds a hearing on the trade case Dec. 6, and the White House has a Jan. 12 deadline to make a final decision. A Trump administration official has said the president is likely to issue tariffs on solar imports, given his protectionist bent.

Merkley didn't go into detail about what kind of incentives he could support, but according to the senator's office, he wouldn't rule out a remedy that could impose quotas on the amount of imports allowed or auction of import licenses, the latter which works kind of like a tariff in that it imposes an extra cost on imported solar panels because companies would have to buy import licenses.

Flashback: Merkley supported a similar, though much narrower, trade case a few years ago, where SolarWorld asked for tariffs against Chinese imports only. This latest case is asking for tariffs against all imports of the most popular kind of solar panel, under the argument Chinese companies have outsourced their manufacturing to other Southeast Asian countries to get around earlier trade barriers.

Between the lines: Merkley is taking a more cautious approach this time around, largely because it's a broader trade request. Oregon's senior senator, Democrat Ron Wyden, has been more outspokenly critical of what cheap imports are doing to domestic solar manufacturers.

Go deeper: Check out my recent Harder Line column on this topic: America's Chinese solar dilemma.

Go deeper

Trump's coronavirus adviser Scott Atlas resigns

Photo: Nicholas Kamm/AFP via Getty

Scott Atlas, a controversial member of the White House coronavirus task force, handed in his resignation on Monday, according to three administration officials who discussed Atlas' resignation with Axios.

Why it matters: President Trump brought in Atlas as a counterpoint to NIAID director Anthony Fauci, whose warnings about the pandemic were dismissed by the Trump administration. With Trump now fixated on election fraud conspiracy theories, Atlas' detail comes to a natural end.

Dave Lawler, author of World
2 hours ago - World

Assassination in Iran sets stage for tense final 50 days of Trump

The funeral ceremony in Tehran. Photo: Iranian Defense Ministry via Getty

Iranian leaders are weighing their response to the assassination of Mohsen Fakhrizadeh, known as the father of Iran’s military nuclear program, who was given a state funeral Monday in Tehran.

The big picture: Iran has accused Israel of carrying out Friday’s attack, but senior leaders have suggested that they’ll choose patience over an immediate escalation that could play into the hands of the Israelis and the outgoing Trump administration.

Updated 3 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Health: Hospital crisis deepens as holiday season nears.
  2. Vaccine: Moderna to file for FDA emergency use authorizationVaccinating rural America won't be easy — Being last in the vaccine queue is young people's next big COVID test.
  3. Politics: Bipartisan group of senators seeks stimulus dealChuck Grassley returns to Senate after recovering from COVID-19.
  4. States: Cuomo orders emergency hospital protocols as COVID capacity dwindles.
  5. Economy: Wall Street wonders how bad economy has to get for Congress to act.
  6. 🎧 Podcast: The state of play of the top vaccines.